相关实验视频

Updated: Jun 2, 2025

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

一种基于OMV的纳米疫苗作为抗原呈现信号增强剂用于癌症免疫治疗

Yichao Lu^1,2,3, Nana Ma^2,3, Keman Cheng^2,3

¹Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu Province, 210029, China.

Advanced materials (Deerfield Beach, Fla.)

|January 15, 2025

概括

这项研究引入了一种使用细菌外膜囊泡的抗原呈现信号增强器 (APSE),以改进癌症疫苗. 通过调节像PD-L1.1这样的免疫检查点,APSE可以增强抗瘤免疫力.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

抗原呈现细胞 (APC) 需要共刺激信号来进行抗瘤免疫.
在APC上编程死亡配体1 (PD-L1) 抑制了抗瘤反应,并降低了癌症疫苗的疗效.
瘤微环境通常表现出高PD-L1表达,导致免疫抑制.

研究的目的:

开发一种新的策略来增强由癌症疫苗发起的抗瘤免疫力.
为了克服PD-L1对瘤微环境中的APCs的抑制作用.
提高癌症疫苗的疗效,特别是对于较少免疫性恶性瘤.

主要方法:

使用细菌外膜囊泡 (OMV) 平台创建一个抗原呈现信号增强器 (APSE).
表面修饰的APSE与PD-L1抗体 (αPD-L1) 针对PD-L1免疫检查点.
评估了APSE在APC中传递瘤抗原和调节协同刺激信号的能力.

主要成果:

由于OMV免疫性,APSE有效地提供瘤抗原并激活APC中的共刺激信号.
在APSE上表面结合的αPD-L1阻断PD-L1,可能恢复CD80功能并增强协同刺激.
证明PD-L1阻断在启动抗瘤免疫力方面的重要性.

结论:

通过调节免疫检查点信号,APSE增强了APC功能和抗瘤免疫力.
APSE平台显示了提高癌症疫苗有效性的承诺,特别是在具有挑战性的瘤类型中.
针对PD-L1与抗原呈现结合,对于有效的癌症免疫疗法至关重要.

关键词:

在PD-L1抗体.抗原呈现信号的信号细菌外膜中的囊泡.癌症疫苗癌症疫苗第二个信号的信号.

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.